Hypertension and COVID-19: A public health perspective
| Autor: | Alka Aggarwal Singh, Asha Shah, Jai Prakash Narain |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: | |
| Zdroj: | International Journal of Noncommunicable Diseases, Vol 5, Iss 2, Pp 90-95 (2020) |
| Druh dokumentu: | article |
| ISSN: | 2468-8827 2468-8835 |
| DOI: | 10.4103/jncd.jncd_34_20 |
| Popis: | As the count for COVID-19 infection and deaths climb around the world, it is pertinent to look at the other pandemic of cardiovascular disease (CVD) and hypertension (HT). These conditions have been found to be the most common underlying conditions around the world. Unlike CVD, HT is not considered an independent risk factor for COVID-19. However, it is a risk factor for CVD and hence needs attention. Globally, HT affects approximately 900 million people and kills an estimated 9 million annually (11% of all deaths). It causes end-organ damage to cardiac, cerebral, and renal systems as well as eyes. However, |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|